• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

HARADA Mamoru  原田 守

ORCIDConnect your ORCID iD *help
… Alternative Names

原田 守  ハラダ マモル

Less
Researcher Number 50260716
Other IDs
External Links
Affiliation (based on the past Project Information) *help 2018 – 2023: 島根大学, 学術研究院医学・看護学系, 教授
2006 – 2017: 島根大学, 医学部, 教授
2003 – 2005: Kurume University, Department of Immunology, Associate Professor, 医学部, 助教授
2000 – 2002: 久留米大学, 医学部, 講師
1994: 九州大学, 生体防御医学研究所, 助手
Review Section/Research Field
Principal Investigator
General surgery / Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor therapeutics / General surgery / Tumor immunology / Biological Sciences
Except Principal Investigator
Urology / Basic Section 56030:Urology-related / Hematology / Biological Sciences
Keywords
Principal Investigator
免疫療法 / 癌 / ペプチド / 免疫学 / CD4陽性T細胞 / 癌抗原 / がん免疫 / がん治療 / p21 / 複合的がん治療 … More / 老化細胞除去薬 / 細胞老化 / 細胞死 / がん細胞 / 複合的がん治療法 / 腫瘍生物学 / がん免疫療法 / 老化 / 抗がん剤 / 集学的がん治療 / 化学療法 / 加齢 / vaccine / peptide / tumor antigen / tumor immunology / ワクチン / 腫瘍免疫 / オートファジー / TRAIL / アポトーシス / 癌免疫療法 / Toll様受容体 / 抗原 … More
Except Principal Investigator
ペプチドワクチン / 腎細胞癌 / 免疫療法 / バイオマーカー / 複合免疫療法 / ペプチド / PDL-1 / HIF-1 / EPOR / 癌ワクチン療法 / 腎細胞がん / 癌ワクチン / HLA-A2 / がんワクチン / Peptide / Taylor made / Dendritic cell / テーラーメード / 樹状細胞 / HLA-A24 / ワクチン療法 / VEGFR / CA9 / アポトーシス / ミトコンドリア / Apaf1 / 免疫異常 / ジーンターゲティング / リンパ球 / p56^<1ck> / CD45 Less
  • Research Projects

    (15 results)
  • Research Products

    (161 results)
  • Co-Researchers

    (24 People)
  •  腎細胞がんに対する癌ワクチンを用いた複合免疫療法の有用性に関する検討

    • Principal Investigator
      植村 天受
    • Project Period (FY)
      2022 – 2024
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Kindai University
  •  New anti-cancer therapy targeting therapy-induced senescent cancer cellsPrincipal Investigator

    • Principal Investigator
      Harada Mamoru
    • Project Period (FY)
      2021 – 2023
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Review Section
      Basic Section 50020:Tumor diagnostics and therapeutics-related
    • Research Institution
      Shimane University
  •  Development of combination immunotherapy with peptide vaccines for renal cell carcinoma.

    • Principal Investigator
      Uemura Hirotsugu
    • Project Period (FY)
      2019 – 2021
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Review Section
      Basic Section 56030:Urology-related
    • Research Institution
      Kindai University
  •  Combined anti-cancer immunotherapy based on the ability of immune responses in aged hostsPrincipal Investigator

    • Principal Investigator
      Harada Mamoru
    • Project Period (FY)
      2017 – 2019
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Tumor therapeutics
    • Research Institution
      Shimane University
  •  Development of the HLA-A2 restricted multi-peptides vaccine for renal cell carcinoma.

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2016 – 2018
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kindai University
  •  Development of multi-peptide tumor vaccine for renal cell carcinoma

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2013 – 2015
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Effective anti-cancer immunotherapy by controling autophagyPrincipal Investigator

    • Principal Investigator
      HARADA Mamoru
    • Project Period (FY)
      2012 – 2014
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Tumor immunology
    • Research Institution
      Shimane University
  •  Development of tailor made peptide vaccines for renal cell carcinoma

    • Principal Investigator
      UEMURA Hirotsugu
    • Project Period (FY)
      2010 – 2012
    • Research Category
      Grant-in-Aid for Scientific Research (B)
    • Research Field
      Urology
    • Research Institution
      Kinki University
  •  Anti-cancer immunotherapy targeting toll-like receptors expressed on cancer cells and killer T cellsPrincipal Investigator

    • Principal Investigator
      HARADA Mamoru
    • Project Period (FY)
      2009 – 2011
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      Shimane University
  •  Study on anti-cancer immunotherapy targeting a tumor marker, SCCAPrincipal Investigator

    • Principal Investigator
      HARADA Mamoru
    • Project Period (FY)
      2006 – 2008
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      Shimane University
  •  Clinical study of cancer immunotherapy with dendritic cells pulsed with Taylor made peptides

    • Principal Investigator
      MUTA Hiromi
    • Project Period (FY)
      2004 – 2005
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      Hematology
    • Research Institution
      KYUSHU UNIVERSITY
  •  CD4陽性ヘルパーT細胞に認識される上皮性癌抗原遺伝子の同定Principal Investigator

    • Principal Investigator
      原田 守
    • Project Period (FY)
      2001
    • Research Category
      Grant-in-Aid for Scientific Research on Priority Areas (C)
    • Review Section
      Biological Sciences
    • Research Institution
      Kurume University
  •  Identification of epithelial cancer-associated antigens and application to cancer vaccinePrincipal Investigator

    • Principal Investigator
      HARADA Mamoru
    • Project Period (FY)
      2001 – 2003
    • Research Category
      Grant-in-Aid for Scientific Research (C)
    • Research Field
      General surgery
    • Research Institution
      Kurume University
  •  Apaf1欠損アポトーシス抵抗性細胞における癌化と細胞死の解析

    • Principal Investigator
      吉田 裕樹
    • Project Period (FY)
      2000
    • Research Category
      Grant-in-Aid for Scientific Research on Priority Areas (C)
    • Review Section
      Biological Sciences
    • Research Institution
      Kyushu University
  •  特異遺伝子欠損マウスにおける免疫応答異常の解析

    • Principal Investigator
      岸原 健二
    • Project Period (FY)
      1994
    • Research Category
      Grant-in-Aid for Scientific Research on Priority Areas
    • Research Institution
      Kyushu University

All 2024 2023 2022 2021 2020 2019 2018 2017 2015 2014 2013 2012 2011 2010 2009 2008 2007 2006 Other

All Journal Article Presentation Book Other

  • [Book] Effects of metronomic chemotherapy on immunity, in “Metronomic chemotherapy” (eds) Bocci G, Francia G.2014

    • Author(s)
      Mamoru Harada
    • Total Pages
      13
    • Publisher
      Springer
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Journal Article] Senolysis of gemcitabine-induced senescent human pancreatic cancer cells.2024

    • Author(s)
      Hoque MM, Iida Y, Kotani H, Harada M.
    • Journal Title

      Cancer Reports

      Volume: 7 Issue: 4

    • DOI

      10.1002/cnr2.2075

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Journal Article] The expression analysis of SerpinB9 in hepatoblastoma microenvironment2024

    • Author(s)
      Hirao Hiroki、Adawy Ahmad、Li Lianbo、Yoshii Daiki、Yano Hiromu、Fujiwara Yukio、Honda Masaki、Harada Mamoru、Yamamoto Masahiro、Komohara Yoshihiro、Hibi Taizo
    • Journal Title

      Pediatric Surgery International

      Volume: 40 Issue: 1 Pages: 55-55

    • DOI

      10.1007/s00383-024-05647-7

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-23K15788, KAKENHI-PROJECT-23K06362, KAKENHI-PROJECT-21K07177, KAKENHI-PROJECT-21K08622
  • [Journal Article] Hypoxia-related carbonic anhydrase 9 induces serpinB9 in cancer cells and apoptosis in T cells via acidosis.2024

    • Author(s)
      Harada M, Kotani H, Iida Y, Tanino R, Minami T, Komohara Y, Yoshikawa K, Uemura H.
    • Journal Title

      Cancer Science

      Volume: in press Issue: 5 Pages: 1-12

    • DOI

      10.1111/cas.16133

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07177, KAKENHI-PROJECT-21K15592
  • [Journal Article] Overexpression of SerpinB9 in non-seminomatous germ cell tumors2023

    • Author(s)
      Anami Toshiki、Ibe Yuki、Li Lianbo、Komohara Yoshihiro、Hirao Hiroki、Harada Mamoru、Yano Hiromu、Fujiwara Yukio、Motoshima Takanobu、Yatsuda Junji、Hibi Taizo、Kamba Tomomi
    • Journal Title

      Medical Molecular Morphology

      Volume: 57 Issue: 1 Pages: 68-75

    • DOI

      10.1007/s00795-023-00374-9

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-23K06362, KAKENHI-PROJECT-21K07177
  • [Journal Article] Modulatory effects of supplementation of <i>Lentinula edodes mycelia</i> extract and?<scp>l</scp>‐arginine on the therapeutic efficacy of immunogenic chemotherapy in colon cancer‐bearing mice2023

    • Author(s)
      Taniura Takahito、Ishitobi Kazunari、Hidaka Masaaki、Harada Mamoru
    • Journal Title

      Microbiology and Immunology

      Volume: 68 Issue: 1 Pages: 15-22

    • DOI

      10.1111/1348-0421.13101

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23K15522, KAKENHI-PROJECT-21K07177
  • [Journal Article] Protective roles of cytoplasmic p21Cip1/Waf1 in senolysis and ferroptosis of lung cancer cells.2022

    • Author(s)
      Koyanagi A, Kotani H, Iida Y, Tanino R, Kartika ID, Kishimoto K, Harada M.
    • Journal Title

      Cell Proliferation,

      Volume: 12 Issue: 12

    • DOI

      10.1111/cpr.13326

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07177, KAKENHI-PROJECT-21K15592
  • [Journal Article] A modulatory effect of L-arginine supplementation on anticancer effects of chemoimmunotherapy in colon cancer-bearing aged mice.2022

    • Author(s)
      Ishitobi K, Iida Y, Kotani H, Taniura T, Notsu Y, Tajima Y, Harada M.
    • Journal Title

      International Immunopharmacology,

      Volume: 113 Pages: 109423-109423

    • DOI

      10.1016/j.intimp.2022.109423

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Journal Article] Hydroxychloroquine promotes Bcl-xL-induced apoptosis in BxPC-3 human pancreatic cancer cells.2022

    • Author(s)
      Hoque MM, Iida Y, Kotani H, Kartika ID, Harada M.
    • Journal Title

      Anticancer Research,

      Volume: 42 Issue: 7 Pages: 3495-3506

    • DOI

      10.21873/anticanres.15836

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-21K07177, KAKENHI-PROJECT-21K15592
  • [Journal Article] T-cell responses and combined immunotherapy against human carbonic anhydrase 9-expressing mouse renal cell carcinoma2021

    • Author(s)
      Harada Mamoru、Iida Yuichi、Kotani Hitoshi、Minami Takafumi、Komohara Yoshihiro、Eto Masatoshi、Yoshikawa Kazuhiro、Uemura Hirotsugu
    • Journal Title

      Cancer Immunology, Immunotherapy

      Volume: 71 Issue: 2 Pages: 339-352

    • DOI

      10.1007/s00262-021-02992-7

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K16393, KAKENHI-PROJECT-19H03794, KAKENHI-PROJECT-21K07177
  • [Journal Article] Protective role of cytoplasmic p21Cip1/Waf1 in apoptosis of CDK4/6 inhibitor‐induced senescence in breast cancer cells2021

    • Author(s)
      Kartika Irna D.、Kotani Hitoshi、Iida Yuichi、Koyanagi Akira、Tanino Ryosuke、Harada Mamoru
    • Journal Title

      Cancer Medicine

      Volume: 10 Issue: 24 Pages: 8988-8999

    • DOI

      10.1002/cam4.4410

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K16393, KAKENHI-PROJECT-21K07177
  • [Journal Article] Pemetrexed Sensitizes Human Lung Cancer Cells to Cytotoxic Immune Cells2020

    • Author(s)
      Okimoto T, Kotani H, Iida Y, Koyanagi A, Tanino R, Tsubata Y, Isobe T, Harada M.
    • Journal Title

      Cancer Sci.

      Volume: ー Issue: 6 Pages: 1910-1920

    • DOI

      10.1111/cas.14401

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K16393, KAKENHI-PROJECT-17K07217
  • [Journal Article] Anticancer Activity of ZnO Nanoparticles Against Human Small-Cell Lung Cancer in an Orthotopic Mouse Model.2020

    • Author(s)
      Tanino R, Amano Y, Tong X, Sun R, Tsubata Y, Harada M, Fujita Y, and Isobe T.
    • Journal Title

      Molecular Cancer Therapeutics

      Volume: 19 Issue: 2 Pages: 502-512

    • DOI

      10.1158/1535-7163.mct-19-0018

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Journal Article] Potential mechanisms of spontaneous regression in patients with B-cell lymphoma: the significance of co-stimulatory molecules in lymphoma cells.2019

    • Author(s)
      Komohara Y, Harada M.
    • Journal Title

      Journal of Clinical and Experimental Hematopathology

      Volume: 59 Issue: 4 Pages: 207-210

    • DOI

      10.3960/jslrt.19026

    • NAID

      130007771311

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Journal Article] Different Sensitivities of Senescent Breast Cancer Cells to Immune Cell-Mediated Cytotoxicity2019

    • Author(s)
      Inao T, Kotani H, Iida Y, Kartika ID, Okimoto T, Tanino R, Shiba E, Harada M.
    • Journal Title

      Cancer Sci.

      Volume: 110(9) Issue: 9 Pages: 2690-2699

    • DOI

      10.1111/cas.14116

    • NAID

      120007002176

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-19K16393, KAKENHI-PROJECT-17K07217
  • [Journal Article] Novel drug-resistance mechanisms of pemetrexed-treated non-small cell lung cancer.2018

    • Author(s)
      Tanino R, Tsubata Y, Harashima N, Harada M, Isobe T.
    • Journal Title

      Oncotarget

      Volume: 9 Issue: 24 Pages: 16807-16821

    • DOI

      10.18632/oncotarget.24704

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Journal Article] Bcl-2 inhibition sensitizes triple-negative humna breast cancer cells to doxorubicin.2018

    • Author(s)
      Inao T, Iida Y, Moritani T, Okimoto T, Tanino R, Kotani H, Harada M.
    • Journal Title

      Oncotarget

      Volume: 9 Issue: 39 Pages: 25545-25556

    • DOI

      10.18632/oncotarget.25370

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K07217, KAKENHI-PROJECT-16K15135
  • [Journal Article] Chloroquine augments TRAIL-induced apoptosis and induces G2/M phase arrest in human pancreatic cancer cells2018

    • Author(s)
      Monma H, Iida Y, Moritani T, Okimoto T, Tanino R, Tajima Y, Harada M.
    • Journal Title

      PLOS ONE

      Volume: 7 Issue: 3 Pages: e0193990-e0193990

    • DOI

      10.1371/journal.pone.0193990

    • NAID

      120006539383

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Journal Article] Contrasting effects of cyclophosphamide on anti-CTLA-4 blockade therapy in two tumor mouse models.2017

    • Author(s)
      Iida Y, Harashima N, Motoshima T, Komohara Y, Eto M, Harada M.
    • Journal Title

      Cancer Science,

      Volume: 108 Issue: 10 Pages: 1974-1984

    • DOI

      10.1111/cas.13337

    • Peer Reviewed / Open Access / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Journal Article] Hypoxia-inducing factor (HIF)-1α-derived peptide capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2017

    • Author(s)
      1.Minami T, Matsumura N, Sugimoto K, Shimizu N, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
    • Journal Title

      Int Immunopharmacol.

      Volume: 44 Pages: 197-202

    • DOI

      10.1016/j.intimp.2017.01.014

    • Peer Reviewed / Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-16H05466, KAKENHI-PROJECT-17K07217
  • [Journal Article] Intermittent chemotherapy can retain the therapeutic potential of anti-CD137 antibody during the late tumor-bearing state.2015

    • Author(s)
      Tongu M, Harashima N, Tamada K, Chen L, Harada M
    • Journal Title

      Cancer Science

      Volume: 106 Issue: 1 Pages: 9-17

    • DOI

      10.1111/cas.12568

    • NAID

      120005982740

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-25290057, KAKENHI-PROJECT-25430150
  • [Journal Article] New polycomb group protein enhancer of zeste homolog (EZH) 2-derived peptide with the potential to induce cancer-reactive cytotoxic T lymphocytes in prostate cancer patients with HLA-A3 supertype alleles2015

    • Author(s)
      Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M A, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
    • Journal Title

      International Immunopharmacology

      Volume: 26 Issue: 1 Pages: 133-138

    • DOI

      10.1016/j.intimp.2015.03.023

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-24592416, KAKENHI-PROJECT-25430150, KAKENHI-PROJECT-25293336
  • [Journal Article] Identification of programmed death ligand 1-derived peptides capable of inducing cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma2015

    • Author(s)
      Minami T., Minami T., Shimizu N., Yamamoto Y., De Velasco MA., Nozawa M., Yoshimura K., Harashima N., Harada M., Uemura H.
    • Journal Title

      Journal of Immunotherapy

      Volume: 38 (7) Issue: 7 Pages: 285-291

    • DOI

      10.1097/cji.0000000000000090

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25430150, KAKENHI-PROJECT-25293336
  • [Journal Article] Bcl-2 family inhibition sensitizes human prostate cancer cells to docetaxel and promotes unexpected apoptosis under caspase-9 inhibition2014

    • Author(s)
      amaki H, Harashima N, Hiraki M, Arichi N, Nishimura N, Shiina H, Naora K, Harada M
    • Journal Title

      Oncotarget

      Volume: 5 Pages: 11399-11412

    • NAID

      120005982736

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24(+) patients with renal cell carcinoma.2014

    • Author(s)
      Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
    • Journal Title

      Int Immunopharmacol.

      Volume: 20 Pages: 59-65

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293336
  • [Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2014

    • Author(s)
      Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H
    • Journal Title

      Int Immunopharmacol.

      Volume: 20 Pages: 59-65

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-25293336
  • [Journal Article] Prognostic impact of programmed cell death 1 ligand 1 expression in human leukocyte antigen class I-positive hepatocellular carcinoma after curative hepatectomy.2014

    • Author(s)
      Umemoto Y, Okano S, Matsumoto Y, Nakagawara H, Matono R, Yoshiya S, Yamashita YI, Yoshizumi T, Ikegami T, Soejima Y, Harada M, Aishima S, Oda Y, Shirabe K, Maehara Y.
    • Journal Title

      J Gastroenterol.

      Volume: not determined Issue: 1 Pages: 65-75

    • DOI

      10.1007/s00535-014-0933-3

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-24390320, KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-26670583, KAKENHI-PROJECT-15K10167
  • [Journal Article] Identification of erythropoietin receptor-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from HLA-A24+ patients with renal cell carcinoma.2014

    • Author(s)
      Minami T, Minami T, Shimizu N, Yamamoto Y, De Velasco M, Nozawa M, Yoshimura K, Harashima N, Harada M, Uemura H.
    • Journal Title

      International Immunopharmacology

      Volume: 20 Issue: 1 Pages: 59-65

    • DOI

      10.1016/j.intimp.2014.02.018

    • Peer Reviewed / Open Access
    • Data Source
      KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-25430150
  • [Journal Article] Transfection of poly(I:C) can induce ROS-triggered apoptosis and IFN-&#61538;-mediated growth arrest in human renal cell carcinoma cells via innate adjuvant receptors and the 2-5A system2014

    • Author(s)
      Harashima N, Minami T, Uemura H, Harada M
    • Journal Title

      Molecular Cancer

      Volume: 13 Issue: 1 Pages: 217-217

    • DOI

      10.1186/1476-4598-13-217

    • Peer Reviewed / Acknowledgement Compliant / Open Access
    • Data Source
      KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-25293336, KAKENHI-PROJECT-25430150
  • [Journal Article] Pifithrin-mu, an inhibitor of heat-shock protein 70, can increase the antitumor effects of hyperthermia against human prostate cancer cells2013

    • Author(s)
      Sekihara M, Harashima N, Tongu M, Tamaki Y, Uchida N, Inomata T, Harada M.
    • Journal Title

      PLoS One

      Volume: 8 Issue: 11 Pages: e78772-e78772

    • DOI

      10.1371/journal.pone.0078772

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-25430150
  • [Journal Article] The HSP70 and autophagy inhibitor pifithrin-mu enhances the antitumor effects of TRAIL on human pancreatic cancer2013

    • Author(s)
      Monma H, Harashima N, et al.
    • Journal Title

      Mol Cancer Ther

      Volume: 12 Issue: 4 Pages: 341-351

    • DOI

      10.1158/1535-7163.mct-12-0954

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23701074, KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-25430150, KAKENHI-PROJECT-25462112
  • [Journal Article] Roles of the PI3 K/Akt pathway and autophagy in TLR3 sig naling-induced apoptosis and growth arr est of human prostate cancer cells2012

    • Author(s)
      Harashima, N., Inao, T., Imamura, R., et. al.
    • Journal Title

      Cancer Immunol. Immunother

      Volume: (in press) Issue: 5 Pages: 667-676

    • DOI

      10.1007/s00262-011-1132-1

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21590329, KAKENHI-PROJECT-21591668, KAKENHI-PROJECT-22501023, KAKENHI-PUBLICLY-23114505, KAKENHI-PROJECT-23390092, KAKENHI-PROJECT-23701074, KAKENHI-PROJECT-24590374
  • [Journal Article] Oral ingestion of Lentinula edodes mycelia extract can restore the antitumor T cell response of mice inoculated with colon-26 cells into the subserosal space of the cecum2012

    • Author(s)
      Harada M, et al.(5人中5番目)
    • Journal Title

      Oncology Reports

      Volume: 27 Pages: 325-332

    • DOI

      10.3892/or.2011.1549

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21591668, KAKENHI-PROJECT-24501331
  • [Journal Article] Role of the PI3K/Akt pathway and autophagy in TLR3 signaling-induced apoptosis and growth arrest of humna prostate cancer cells.2012

    • Author(s)
      Harashima N, Inao T, Imamura R, Okano S, Suda T, Harada M.
    • Journal Title

      Cancer Immunology, Immunotherapy

      Volume: 61 Pages: 667-676

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Journal Article] Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo2012

    • Author(s)
      Miki Tongu, Nanae Harashima, Hiroyuki Monma, Touko Inao, Takaya Yamada, Hideyuki Kawauchi, Mamoru Harada
    • Journal Title

      Cancer Immunol Immunother

      Volume: 62 Issue: 2 Pages: 383-391

    • DOI

      10.1007/s00262-012-1343-0

    • NAID

      120005982738

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23659796, KAKENHI-PROJECT-23701074, KAKENHI-PROJECT-24501331
  • [Journal Article] Antitumor effects of cytoplasmic delivery of an innate adjuvant receptor ligand, poly(I : C), on human breast cancer2012

    • Author(s)
      Harada M., et al.(8人中8番目)
    • Journal Title

      Breast Cancer Research and Treatment

      Volume: (in press) Issue: 1 Pages: 89-100

    • DOI

      10.1007/s10549-011-1930-3

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21591668, KAKENHI-PROJECT-22501023, KAKENHI-PROJECT-23701074, KAKENHI-PROJECT-24501331
  • [Journal Article] Combining a peptide vaccine with oral ingestion of Lentinula edodes mycelia extract enhances anti-tumor activity in B16 melanoma-bearing mice2012

    • Author(s)
      Harada M., et al.(7人中7番目)
    • Journal Title

      Cancer Immunology Immunotherapy

      Volume: (in press)

    • URL

      http://www.springerlink.content/0340-7004.

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Journal Article] Combining a peptide vaccine with oral ingestion of Lentinula edodes mycelia extract enhances anti-tumor activity in B16 melanoma-bearing mice2012

    • Author(s)
      Tanaka K, Harashima N, et al.
    • Journal Title

      Cancer Immunol Immunother

      Volume: 61 Issue: 11 Pages: 2143-2152

    • DOI

      10.1007/s00262-012-1275-8

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-23701074, KAKENHI-PROJECT-24501331
  • [Journal Article] Oral ingestion of Lentinus edodes mycelia extract inhibits B16 melanoma growth via mitigation of regulatory T cell-mediated immunosuppression2011

    • Author(s)
      Harada M, et al.(6人中6番目)
    • Journal Title

      Cancer Science

      Volume: 102 Issue: 3 Pages: 516-521

    • DOI

      10.1111/j.1349-7006.2010.01841.x

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Journal Article] Interleukin-17A is involved in enhancement of tumor progression in murine intestine2011

    • Author(s)
      K.Oshiro
    • Journal Title

      Immunobiology

      Volume: 217 Issue: 1 Pages: 54-60

    • DOI

      10.1016/j.imbio.2011.08.002

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-20220009, KAKENHI-PROJECT-21390132, KAKENHI-PROJECT-21591668, KAKENHI-PROJECT-24501331, KAKENHI-PROJECT-21390303
  • [Journal Article] Provision of continuous maturation signaling to dendritic cells by RIG-1-stimulating cytosolic RNA synthesis of Sendai virus2011

    • Author(s)
      Okano S,, et al
    • Journal Title

      J Immunol

      Volume: 186 Issue: 3 Pages: 1828-39

    • DOI

      10.4049/jimmunol.0901641

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21249072, KAKENHI-PROJECT-21390364, KAKENHI-PROJECT-21591668, KAKENHI-PROJECT-22659246, KAKENHI-PLANNED-22133009
  • [Journal Article] 'Sterile' inflammation and autophagy in cancer immunotherapy2010

    • Author(s)
      Harada M, Harashima N
    • Journal Title

      Immunotherapy

      Volume: 2 Issue: 5 Pages: 599-601

    • DOI

      10.2217/imt.10.55

    • Data Source
      KAKENHI-PROJECT-21591668
  • [Journal Article] Immunogenic chemotherapy with cyclophophamide and doxorubicin against established murine carcinoma2010

    • Author(s)
      Harada M, et al.(5人中5番目)
    • Journal Title

      Cancer Immunology Immunotherapy

      Volume: 59 Issue: 5 Pages: 769-777

    • DOI

      10.1007/s00262-009-0797-1

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Journal Article] 'Sterile' inflammation and autophagy in cancer immunotherapy2010

    • Author(s)
      Harada M
    • Journal Title

      Immunotheray

      Volume: Vol.2 Pages: 599-601

    • Data Source
      KAKENHI-PROJECT-21591668
  • [Journal Article] Allogeneic cell therapy from immuniz ed donors with tumor antigen peptide enhances the antitumor effect after cyclophosphamide-using non-myeloabl ative allogeneic hematopoietic cell transplantation2009

    • Author(s)
      Hamaguchi M, Eto M 他8名
    • Journal Title

      Cancer Sci

      Volume: 100巻 Issue: 1 Pages: 138-143

    • DOI

      10.1111/j.1349-7006.2008.01014.x

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21390295, KAKENHI-PROJECT-21591668
  • [Journal Article] Roles of proinflammatory cytokines and the Fas/FasL interaction in pathogenesis of inflammatory myopathies2009

    • Author(s)
      Harada M., et al.(8人中8番目)
    • Journal Title

      Immunology

      Volume: 128 Issue: 1pt2 Pages: 589-599

    • DOI

      10.1111/j.1365-2567.2008.03039.x

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Journal Article] Delayed growth of EL4 lymphoma in SR-A-deficient mice is due to up-regulation of nitric oxide and IFN-production by tumor-associated macrophages2009

    • Author(s)
      Harada M, et al.(8人中8番目)
    • Journal Title

      Cancer Science

      Volume: 100 Issue: 11 Pages: 2160-2166

    • DOI

      10.1111/j.1349-7006.2009.01296.x

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Journal Article] Roles of proinflammatory cytokines and theFas/FasL interaction in pathogenesis ofInflammatory myopathies.2009

    • Author(s)
      Kondo M, Harada M. et al.(6人中6番目)
    • Journal Title

      Immunology in press

      Pages: 0-0

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Allogeneic cell therapy from immunized donors with tumor antigen peptide enhances the anitumor effect after cyclophosphamide-using nonmyeloablative allogenenic hematopoietic cell transplantation in mice.2009

    • Author(s)
      Hamaguchi M, Harada M, et al..(10人中8番目)
    • Journal Title

      Cancer Science 100

      Pages: 138-143

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Posttransplant administration of cyclophosphamide and donor lymphocyte infusion induces potent antitumor immunity to solid tumor.2008

    • Author(s)
      Eto M, Harada M,et al.(12人中6番目)
    • Journal Title

      Clinical Cancer Research 14

      Pages: 2833-2840

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] A correlation between symptom severity and unbalanced reactive IgA production in Japanese ceder pollinosis patients.2008

    • Author(s)
      Komatsu N, Harada M,et al.(8人中2番目)
    • Journal Title

      Asian Pacific Journal of Allergy and Immunology 26

      Pages: 97-104

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Identification of Eph6 variant-derived epitope peptides recognized by cytotoxic T-lymphocytes from HLA-A24+ malignant glioma patients2008

    • Author(s)
      Jin M, Harada M,et al.(9人中4番目)
    • Journal Title

      Oncology Reports 19

      Pages: 1277-1283

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Identification of target antigens in specific immunotherapy for renal cell carcinoma2007

    • Author(s)
      Komohara Y, Harada M, et al.(8人中2番目)
    • Journal Title

      Journal of Urology 177

      Pages: 1157-1162

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Identification of SART3-derived peptides having the potential to induce cancer-reactive cytotoxic T lymphocytes from prostate cancer patients with HLA-A3 supertype alleles2007

    • Author(s)
      Minami T, Harada M. et al.(8人中8番目)
    • Journal Title

      Cancer Immunology Immunotherapy 56

      Pages: 689-698

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Kinesin superfamily protein-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in HLA-A24+ glioma patients2007

    • Author(s)
      Harada, M.
    • Journal Title

      Oncology Reports 17

      Pages: 629-636

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Immunological evaluation of neoadjuvant peptide vaccination before radical prostatectomy for patients with localized prostate cancer.2007

    • Author(s)
      Noguchi M, Harada M, et al.(6人中3番目)
    • Journal Title

      Prostate 67

      Pages: 933-942

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Combination therapy of personalized peptide vaccination and low-dose estramustine phosphate for metastatic hormone refractory prostate cancer patients: An analysis of prognostic factors in the treatment2007

    • Author(s)
      Noguchi M, Harada M,et al.(10人中7番目)
    • Journal Title

      Oncology Research 16

      Pages: 341-349

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Differential levels of human leukocyte antigen-class I, multidrug-resistance 1 and androgen receptor expressions in untreated prostate cancer cells: The robustness of prostate cancer.2007

    • Author(s)
      Homma S, Harada M,et al.(7人中3番目)
    • Journal Title

      Oncology Reports 18

      Pages: 343-346

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Identification of Lck-derived peptides applicable to anti-cancer vaccine for patients with human leukocyte antigen-A3 supertype alleles2007

    • Author(s)
      Naito M, Harada M. et al.(9人中9番目)
    • Journal Title

      British Journal of Cancer 97

      Pages: 1648-1654

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Immunological evaluation of personalized peptide vaccination in combination with a 5-fluorouracil derivative (TS-1) for advanced gastric or colorectal carcinoma patients.2007

    • Author(s)
      Sato Y, Harada M, et al.(14人中13番目)
    • Journal Title

      Cancer Science 98

      Pages: 1113-1119

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype allelels.2007

    • Author(s)
      Matsueda S, Harada M. et al.(8人中8番目)
    • Journal Title

      Journal of Immunotherapy 30

      Pages: 274-281

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Cyclophosphamide-using nonmyeloablative allogeneic cell therapy against renal cancer with a reduced risk of graft-versus-host disease.2007

    • Author(s)
      Eto M, Harada M, et al.(10人中4番目)
    • Journal Title

      Clinical Cancer Research 13

      Pages: 1029-1035

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] peptides of the polycomb group protein enhancer of zeste homolog 2 (EZH2) with the potential to induce cancer-reactive cytotoxic T lymphocytes in HLA-A2^+ prostate cancer patients.2007

    • Author(s)
      Itoh Y, Harada M. et al.(8人中8番目)
    • Journal Title

      Oncology Reports 18

      Pages: 1231-1237

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] HLA-G as a target molecule in specific immunotherapy against renal cell carcinoma2007

    • Author(s)
      Komohara Y, Harada M,et al.(8人中2番目)
    • Journal Title

      Oncology Reports 18

      Pages: 1463-1468

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Kinesin superfamily protein-derived peptides with the ability to induce glioma-reactive cytotoxic T lymphocytes in HLA-A24^+ glioma patients.2007

    • Author(s)
      Harada M, et al.(4人中1番目)
    • Journal Title

      Oncology Reports 17

      Pages: 629-636

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] In vivo growth of transitional and renal carcinoma cell lines can be suppressed by adenovirus-mediated expression of a solubleform of vascular endothelial growth factor receptor2006

    • Author(s)
      Ichikura H, Harada M,et al.(8人中4番目)
    • Journal Title

      Oncology Reports 15

      Pages: 1333-1337

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Identification of Hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24^+ and HCV2a-infected patients2006

    • Author(s)
      Wang Y, Harada M, et al.(3人中8番目)
    • Journal Title

      Cellular Immunology 241

      Pages: 38-46

    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Prostate-specific antigen-reactive cytotoxic T lymphocyte precursors in colon cancer patients2006

    • Author(s)
      Wang Y, Harada M,et al.(7人中2番目)
    • Journal Title

      Oncology Reports 15

      Pages: 317-321

    • NAID

      120005587482

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] new epitope peptides derived from Hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA- A2^+ HCV-infected patients2006

    • Author(s)
      Wang Y, Harada M, et al.(8人中3番目)
    • Journal Title

      Microbiol. Immunol 50

      Pages: 857-865

    • NAID

      10018398215

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Identification of squamous cell carcinoma antigen-derived peptides having the capacity of inducing cancer-reactive CTLs in HLA-A24^+ cancer patients2006

    • Author(s)
      Homma, Harada M,et al.(2人中12番目)
    • Journal Title

      International Journal of Oncology 29

      Pages: 577-587

    • NAID

      120005587483

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Anti-cancer vaccine candidates in specific immunotherapy for bladder carcinoma2006

    • Author(s)
      Komohara Y, Harada M, et al.(2人中8番目)
    • Journal Title

      International Journal of Oncology 29

      Pages: 1555-60

    • NAID

      120005587481

    • Peer Reviewed
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Journal Article] Anti-tumor effect of systemic and local immunization with a cytotoxic T lymphocyte-directed peptide in combination with a local injection of OK-4322006

    • Author(s)
      Ono T, Harada M, et al.(10人中2番目)
    • Journal Title

      Clinical Cancer Research 12

      Pages: 1325-1332

    • Data Source
      KAKENHI-PROJECT-18591449
  • [Presentation] Anti-tumor effect of CCL19-expressing allogeneic mesenchymal stromal cells2024

    • Author(s)
      Yuichi Iida, Mamoru Harada
    • Organizer
      第52回日本免疫学会総会
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] CCL19発現アロ間葉系細胞の抗腫瘍メカニズムの検討2023

    • Author(s)
      飯田雄一、原田守
    • Organizer
      第27 回がん免疫学会総会
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] 免疫療法抵抗性に関与する低酸素応答関連分子 serpinB92023

    • Author(s)
      原田守
    • Organizer
      第27 回がん免疫学会総会
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] Pemetrexed-induced ferroptosis in A549 human lung cancer cells and a protective role of p212023

    • Author(s)
      Harada Mamoru, Iida Yuchi, Hoque Mahbubul M, Kotani Hitosh
    • Organizer
      第82回日本癌学会総会
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] Senolysis of gemcitabine-induced senescent human pancreatic cancer cells2023

    • Author(s)
      Hoque Mohammad Mahbubul, Yuichi Iida, Hitoshi Kotani, Mamoru Harada
    • Organizer
      第82回日本癌学会総会
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] 2種類の同系大腸がんマウスモデルを用いた複合的免疫化学療法。2022

    • Author(s)
      谷浦隆仁、飯田雄一、小谷仁司、石飛一成、平原典幸、田島義証、原田守
    • Organizer
      第26回がん免疫学会総会
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] Protective roles of p21Cip1/Waf1 in cell death of therapy-induced senescent cancer cells.2022

    • Author(s)
      Mamoru Harada
    • Organizer
      第81回 日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] アロCCL19発現同種間葉系細胞の抗腫瘍効果の検討。2022

    • Author(s)
      飯田雄一、原田守
    • Organizer
      第26回がん免疫学会総会
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] 低酸素環境で誘導される免疫抵抗性。2022

    • Author(s)
      原田守
    • Organizer
      第26回がん免疫学会総会
    • Invited
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] A novel immunotherapy using CCL19-expressing allogeneic mesenchymal stromal cells exerts anti-tumor effect by increasing CD103+ CD8+ T cells.2022

    • Author(s)
      Yuichi Iida, Mamoru Harada
    • Organizer
      第51回日本免疫学会総会
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] SerpinB9, a hypoxic response-related molecule responsible for immunotherapy resistance.2022

    • Author(s)
      Mamoru Harada, Yuichi Iida, and Hitoshi Kotani
    • Organizer
      第51回日本免疫学会総
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] ヒトCA9 発現マウス腎がんに対する免疫チェックポイント阻害とaxitinib による複合がん療法2021

    • Author(s)
      原田守、飯田雄一、菰原義弘、小谷仁司
    • Organizer
      第80回日本癌学会
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] アロCCL19発現同種間葉系細胞の腫瘍残存および抗腫瘍効果の検討2021

    • Author(s)
      飯田雄一、原田守
    • Organizer
      第25回がん免疫学会
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] 老化誘導剤アフィジコリンと老化細胞除去薬ABT-263のヒト乳がんと肺がん細胞に対する併用効果2021

    • Author(s)
      小谷仁司、谷野良輔、飯田雄一、原田守
    • Organizer
      第80回日本癌学会
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] ヒトcarbonic anhydrase 9 を発現した ‘cold’ マウス腎がんに対する複合がん免疫療法2021

    • Author(s)
      原田守、小谷仁司、菰原義弘、飯田雄一
    • Organizer
      第25回がん免疫学会
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] Anti-tumor immunotherapy using CCL19-expressing allogeneic mesenchymal stromal cells2021

    • Author(s)
      Iida Y, Harada M
    • Organizer
      第50回日本免疫学会
    • Data Source
      KAKENHI-PROJECT-21K07177
  • [Presentation] Identification of a candidate that suppresses the differentiation of na&iuml;ve helper T cells to regulatory T cells via screening of herbal crude drugs.2019

    • Author(s)
      Kotani H, Iida Y, Harada M.
    • Organizer
      第48回日本免疫学会総会
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] Senescent breast cancer cells induced by doxorubicin or the CDK4/6 inhibitor abemaciclib show different sensitivities to immune cell-mediated cytotoxicity.2019

    • Author(s)
      Harada M, Kotani H, Iida Y.
    • Organizer
      第48回日本免疫学会総会
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] Local deliver of CCL19-expressing mesenchymal stromal cells augments the therapeutic efficacy by anti-PD-L1 blockade antibody via promoting infiltration of immune cells.2019

    • Author(s)
      Iida Y, Yoshikawa R, Murata A, Kotani H, Matsuzaki Y, Harada M.
    • Organizer
      第48回日本免疫学会総
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] Supplementation of L-arginine augments antitumor effects induced by chemotherapy and immune checkpoint blockade therapy.2019

    • Author(s)
      佐藤悠介, 小谷仁司、飯田雄一、谷浦隆仁、原田守。
    • Organizer
      第78回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] Local injection of CCL19-expressing mesenchymal stem cells augments the therapeutic efficacy of anti-PD-L1 antibody by promoting infiltration of immune cells.2019

    • Author(s)
      Iida Y, Yoshikawa R, Murata A, Kotani H, Matsuzaki Y, Harada M.
    • Organizer
      第23回がん免疫学会
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] Different sensitivities of senescent breast cancer cells to immune cell-mediated cytotoxicity2019

    • Author(s)
      原田守, 小谷仁司、飯田雄一、稲尾瞳子
    • Organizer
      第78回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] Doxorubicinはヒト乳がん細胞にsenescenceを誘導し細胞傷害性免疫細胞に対する感受性を増強させる2018

    • Author(s)
      稲尾瞳子、原田守
    • Organizer
      第26回日本乳がん学会
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] Anti-cancer drugs induce senescence in cancer cells and increase their sensitivity to CAR-T cells2018

    • Author(s)
      Harada M, Okimoto T, Inao T, Tanino R, iida Y, Isobe T.
    • Organizer
      第77回日本癌学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] Local delivery of CCL19-expressing mesenchymal stromal cells suppresses the tumor growth via promoting infiltration of immune cells.2018

    • Author(s)
      Iida Y, Yoshikawa R, Murata A, Matsuzaki Y, Harada M
    • Organizer
      第47回日本免疫学会総会
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] Doxorubicin induces cellular senescence in human breast cancer cells and sensitizes them to cytotoxic T-lymphocytes.2018

    • Author(s)
      Inao T, Iida Y, Kotani H, Harada M.
    • Organizer
      San Antonio Breast Cancer Symposium.
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] p53遺伝子変異を有するトリプルネガティブ乳癌細胞株に対するdoxorubicinとBcl-2 阻害剤(ABT-199)の併用効果2018

    • Author(s)
      稲尾瞳子、原田守
    • Organizer
      第118回日本外科学会学術総会
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] Chemotherapy-induced senescent cancer cells are good targets for T cell-based anti-cancer immunotherapy2018

    • Author(s)
      Harada M, Kotani H, Iida Y.
    • Organizer
      第47回日本免疫学会総会
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] 間葉系幹細胞の腫瘍局所残存性を利用した新規抗がん免疫療法のマウスモデルの確立2018

    • Author(s)
      飯田雄一、吉川倫太郎、松崎有未、原田守
    • Organizer
      第22回がん免疫学会
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] 抗がん剤pemetrexedでsenescence に陥ったヒト肺がん細胞は細胞傷害性T細胞に傷害されやすい2018

    • Author(s)
      原田守、沖本民生、谷野良輔、飯田雄一、礒部威
    • Organizer
      第22回がん免疫学会
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] Pemetrexed-resistant non-small cell lung cancer cell lines have novel drug-resistance mechanisms.2017

    • Author(s)
      Tanino R, Tsubata Y, Harashima N, Harada M, Isobe T.
    • Organizer
      世界肺癌学会(WCLC2017)
    • Int'l Joint Research
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] Pros and cons of cyclophosphamide in anti-CTLA-4 antibody-treated different tumor mouse models2017

    • Author(s)
      飯田雄一、原嶋奈々江、元島崇信、菰原義弘、江藤正俊、原田守
    • Organizer
      第21回日本がん免疫学会
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] トリプルネガティブ乳癌細胞株に対するdoxorubicinとBcl-2 阻害剤の併用効果2017

    • Author(s)
      稲尾瞳子、原嶋奈々江、原田守
    • Organizer
      第25回日本乳癌学
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] Contrasting interaction between cyclophosphamide and anti-CTLA-4 therapy in different mouse tumor models.2017

    • Author(s)
      原田守、飯田雄一、原嶋奈々江、元島崇信、菰原義弘、江藤正俊
    • Organizer
      第76回日本癌学会
    • Data Source
      KAKENHI-PROJECT-17K07217
  • [Presentation] A novel HSP70 inhibitor pifithrin-mu enhances the antitumor effect of radiation on human prostate cancer.2013

    • Author(s)
      Sekihara K, Harashima N, Tamaki Y, Hieda Y, Uchida N, Inomata T, Harada M
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] Mechanisms of an HSP70 inhibitor pifithrin-mu to enhance TRAIL-induced apoptosis of pancreatic cancer cells2013

    • Author(s)
      Monma H, Harashima N, Hari Y, Tajima Y, Harada M
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] Restoration of the TRAIL susceptibility of human pancreatic cancer cells by inhibition2013

    • Author(s)
      Harashima N, Hari Y, Monma H, Tajima Y, Harada M
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] Long-lasting suppression of CT26 growth after low-dose chemotherapy with cyclophosphamide plus gemcitabine followed by anti-CD137 antibody.2013

    • Author(s)
      Harada M, Okano S, Tanada K, Harashima N
    • Organizer
      第42回日本免疫学会学術総会
    • Place of Presentation
      幕張メッセ(千葉)
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] Poly(I:C)トランスフェクションによるROS産生を伴った癌細胞死誘導とインターフェロン制御分子の関与2013

    • Author(s)
      原嶋奈々江、岡野慎士、原田守
    • Organizer
      第17回日本がん免疫学会
    • Place of Presentation
      全日空ホテル(宇部)
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] 低用量 chemotherapyと抗CD137抗体の併用により誘導される持続的な抗腫瘍免疫応答2013

    • Author(s)
      頓宮美樹、原嶋奈々江、山田高也、岡野慎士、玉田耕治、原田守
    • Organizer
      第17回日本がん免疫学会
    • Place of Presentation
      全日空ホテル(宇部)
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] HSP70阻害剤pifithrin-muがPanc-1膵癌細胞に対するTRAIL誘導性アポトーシスを増強する機序2013

    • Author(s)
      門馬浩行、原嶋奈々江、波里瑶子、田島 義証、原田守
    • Organizer
      第17回日本がん免疫学会
    • Place of Presentation
      全日空ホテル(宇部)
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] CD4 T cell-mediated masking effects of the immunogenicity of tumor-associated antigens are qualitatively and quantitatively different depending on the individual antigens2013

    • Author(s)
      Okano S, Yamashita Y, Harashima N, Ikegami T, Yoshizumi T, Shirabe K, Harada M, Yoshikai Y, and Maehara Y
    • Organizer
      第72回日本癌学会学術総会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] Neoadjuvant immunotherapy using IL12/DC for control of recurrent hepatocellular carcinoma in immunosppressed mice2011

    • Author(s)
      Harada Mamoru
    • Organizer
      第70回日本癌学会総会,第40回日本免疫学会総会
    • Place of Presentation
      幕張メッセ(千葉)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] Neoadjuvant immunotherapy using IL12/DC for control of recurrent hepatocellular carcinoma in immunosuppressed mice2011

    • Author(s)
      原田守
    • Organizer
      第15回日がん免疫学会総会
    • Place of Presentation
      千里ライフサイエンスセンター(大阪)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] Lentinula edodes mycelia抽出物の予防的経口摂取はTreg抑制を介してワクチンによる抗癌効果を増強する2011

    • Author(s)
      原田守
    • Organizer
      第70回日本癌学会総会
    • Place of Presentation
      名古屋コングレスセンター(名古屋)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] Apoptosis and ROS production in ploy(I : C)-transfected human renal cell carcinoma2011

    • Author(s)
      Harada Mamoru
    • Organizer
      第40回日本免疫学会総会
    • Place of Presentation
      幕張メッセ(千葉)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] Role of autophagy in apoptosis of human cancer cells after stimulation through innate adjuvant receptor2011

    • Author(s)
      Harada Mamoru
    • Organizer
      第40回日本免疫学会総会
    • Place of Presentation
      幕張メッセ(千葉)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] 乳癌細胞に発現するアジュバント受容体を利用したimmunogenic cancer cell deathの誘導2011

    • Author(s)
      原田守
    • Organizer
      第15回日がん免疫学会総会
    • Place of Presentation
      千里ライフサイエンスセンター(大阪)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] Poly(I : C)トランスフェクションによるヒト乳癌細胞に対する抗がん効果とオートファジー2011

    • Author(s)
      原田守
    • Organizer
      第70回日本癌学会総会
    • Place of Presentation
      名古屋コングレスセンター(名古屋)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] Lentinula edodes mycelia抽出物の経口摂取はTreg抑制により抗癌ペプチドワクチン効果を増強・持続させる2011

    • Author(s)
      原田守
    • Organizer
      第70回日本癌学会総会
    • Place of Presentation
      名古屋コングレスセンター(名古屋)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] TregとMDSCをターゲットとしたシクロホスファマイドとゲムシタビンの間欠投与による化学療法2011

    • Author(s)
      原田守
    • Organizer
      第70回日本癌学会総会
    • Place of Presentation
      名古屋コングレスセンター(名古屋)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] 移植後肝細胞癌再発抑制におけるIL-12と樹状細胞を用いた術前補助免疫療法の抗腫瘍効果の検討2011

    • Author(s)
      原田守
    • Organizer
      第70回日本癌学会総会
    • Place of Presentation
      名古屋コングレスセンター(名古屋)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] Role of autophagy in apoptosis of human cancer cells after stimulation throush innate adjuvant receptor2011

    • Author(s)
      Harada M
    • Organizer
      第40回日本免疫学会総会
    • Place of Presentation
      千葉(幕張メッセ)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] TLR3シグナルはPI3K/Akt経路の不活化を介してヒト前立腺癌細胞に細胞死と増殖抑制を誘導する2010

    • Author(s)
      原田守
    • Organizer
      第14回日本がん免疫学会総会
    • Place of Presentation
      ホテル熊本(熊本)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] Provision of continuous maturation signaling to dendritic cells(DC) by RIG-1-stimulating cytosolic RNA synthesis of recombinant Sendai virus(rSeV)2010

    • Author(s)
      Harada Mamoru
    • Organizer
      国際免疫学会
    • Place of Presentation
      神戸国際会議場(神戸)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] TLR3 ligand-induced apoptotic cell death with autophagy and growth arrest in human prostate cancer cells2010

    • Author(s)
      Harada Mamoru
    • Organizer
      国際免疫学会
    • Place of Presentation
      神戸国際会議場(神戸)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] シイタケ菌糸体抽出物によるTreg免疫抑制の解除を介した腫瘍特異的CTLの誘導2010

    • Author(s)
      原田守
    • Organizer
      第69回日本癌学会総会
    • Place of Presentation
      大阪国際会議場(大阪)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] リコンビナントセンダイウイルスによるRIG-1刺激性細胞内RNA合成はヒト樹状細胞の新規刺激剤である2010

    • Author(s)
      原田守
    • Organizer
      第69回日本癌学会総会
    • Place of Presentation
      大阪国際会議場(大阪)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] Induction of apoptosis and growth arrest of human breast cancer cells by targeting a cytoplasmic RIG-I-like receptor2010

    • Author(s)
      Harada Mamoru
    • Organizer
      The 20^<th> HCS-The three Universities' Consortium International Symposium
    • Place of Presentation
      広島国際会議場
    • Year and Date
      2010-10-31
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] Poly(I : C)のトランスフェクションによるヒト乳癌細胞でのアポトーシスとオートファジーの誘導2010

    • Author(s)
      原田守
    • Organizer
      第69回日本癌学会総会
    • Place of Presentation
      大阪国際会議場(大阪)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] RIG-1-stimulating cytosolic RNA synthesis of Sendai virus(rSeV) is a novel stimulant for human dendritic cells2010

    • Author(s)
      原田守
    • Organizer
      第14回日本がん免疫学会総会
    • Place of Presentation
      ホテル熊本(熊本)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] Immunogenic chemotherapy with cyclophosphamide and adriamycin against established murine colon carcinoma2009

    • Author(s)
      原田守
    • Organizer
      第13回日本がん免疫学会総会
    • Place of Presentation
      北九州国際会議場(北九州)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] TLR3 ligand-induced prostate cancer cell death through endogenous production of type I IFN2009

    • Author(s)
      Harada Mamoru
    • Organizer
      第68回日本癌学会総会
    • Place of Presentation
      パシフィコ横浜(横浜)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] Immunogenic chemotherapy with cyclophosphamide and adriamycin against established murine colon carcinoma2009

    • Author(s)
      原田守
    • Organizer
      第13回日本がん免疫学会総会
    • Place of Presentation
      北九州
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] TLR3 ligand-induced apoptosis of prostate cancer cells2009

    • Author(s)
      Harada M
    • Organizer
      第39回日本免疫学会総会
    • Place of Presentation
      大阪
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] TLR3 ligand-induced apoptosis of prostate cancer cells2009

    • Author(s)
      Mamoru Harada
    • Organizer
      第39回日本免疫学会総会
    • Place of Presentation
      大阪国際会議場(大阪)
    • Data Source
      KAKENHI-PROJECT-21591668
  • [Presentation] Roles of pro- inflammatory cytokines and Fas in the pathogenesis of inflammatory myopathies2008

    • Author(s)
      HARADA Mamoru
    • Organizer
      第38回日本免疫学会総会
    • Place of Presentation
      京都
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Presentation] Cyclophosphamideとadriacycinによる抗がん免疫応答の増強2008

    • Author(s)
      原田守
    • Organizer
      第67回日本癌学会学術総会
    • Place of Presentation
      名古屋
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Presentation] 同種造血幹細胞移植後の腎細胞癌患者由来T細胞が認識する新規腫瘍抗原の同定とその発現2008

    • Author(s)
      原田守
    • Organizer
      第12回基盤的癌免疫研究会総会
    • Place of Presentation
      埼玉
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Presentation] TRP2 を認識するlow avidity CD8+ T細胞の胸腺外分化/Evidence of the extrathymic development of tyrosinae-related protein (TRP)2-recognizing CD8+ T cells with low avidity2007

    • Author(s)
      HARADA Mamoru
    • Organizer
      第37回日本免疫学会総会
    • Place of Presentation
      東京
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Presentation] Evidence of the extrathymic development of tyrosinase-related protein(TRP)2-recognizing CD8+T cells with Iow avidity2007

    • Author(s)
      Harada, M.
    • Organizer
      第37回日本免疫学会
    • Place of Presentation
      東京
    • Year and Date
      2007-11-22
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Presentation] Vaccination of donors with tumor antigen peptides enhances antitumor effects in nonmyeloablative allogenenic cell therapy2007

    • Author(s)
      HARADA Mamoru
    • Organizer
      第66回日本癌学会総会
    • Place of Presentation
      横浜
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Presentation] 腎癌・膀胱癌に対するワクチン療法に有用な抗原ペプチドの検討2006

    • Author(s)
      原田守
    • Organizer
      第65回日本癌学会学術集総会
    • Place of Presentation
      横浜
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Presentation] Kinesin superfamily protein-derived peptides with the ability to induce glioma-reactive CTLs in HLA-A24+ glioma patients2006

    • Author(s)
      HARADA mamoru
    • Organizer
      第36回日本免疫学会総会・学術集会
    • Place of Presentation
      大阪
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Presentation] 未治療前立腺癌組織でのHLAクラスI,MRP1とアンドロゲンレセプター発現の検討2006

    • Author(s)
      原田守
    • Organizer
      第65回日本癌学会学術集総会
    • Place of Presentation
      横浜
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Presentation] 前立腺癌患者再燃早期におけるテーラーメイドペプチドワクチン療法の可能性2006

    • Author(s)
      原田守
    • Organizer
      第65回日本癌学会学術集総会
    • Place of Presentation
      横浜
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Presentation] Identification of SART3- derived peptides having the potential to induce cancer-reactive CTLs from prostate cancer patients with HLA-A3 supertype alleles2006

    • Author(s)
      HARADA Mamoru
    • Organizer
      第36回日本免疫学会総会・学術集会
    • Place of Presentation
      大阪
    • Data Source
      KAKENHI-PROJECT-18591449
  • [Presentation] 抗がん剤やBRMによる免疫抑制の軽減と抗がんT細胞応答の誘導

    • Author(s)
      原田守
    • Organizer
      第52回日本癌治療学会
    • Place of Presentation
      パシフィコ横浜(横浜市)
    • Year and Date
      2014-08-28 – 2014-08-30
    • Invited
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] HIF-2&#61537;の阻害はヒト膵がん細胞のTRAIL感受性を増強する

    • Author(s)
      原嶋奈々江、波里瑶子、門馬浩行、秋元美穂、竹永啓三、田島義証、原田守
    • Organizer
      第73回日本癌学会総会
    • Place of Presentation
      パシフィコ横浜(横浜市
    • Year and Date
      2014-09-25 – 2014-09-27
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] ABT-263はヒト前立腺癌PC3細胞のドセタキセル感受性を増強する

    • Author(s)
      玉木宏樹、原嶋奈々江、原田守
    • Organizer
      第73回日本癌学会総会
    • Place of Presentation
      パシフィコ横浜(横浜市
    • Year and Date
      2014-09-25 – 2014-09-27
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] Bcl-2 family 阻害剤によるヒト膵癌細胞のTRAIL抵抗性の克服

    • Author(s)
      波里瑶子、原嶋奈々江、門馬浩行、田島義証、原田守
    • Organizer
      第18回日本がん免疫学会
    • Place of Presentation
      ひめぎんホール(松山市)
    • Year and Date
      2014-07-30 – 2014-08-01
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] :低酸素誘導因子 HIF 阻害によるヒト膵癌細胞のTRAIL感受性の増強

    • Author(s)
      原嶋奈々江、門馬浩行、波里瑶子、秋元美穂、竹永啓三、原田守
    • Organizer
      第18回日本がん免疫学会
    • Place of Presentation
      ひめぎんホール(松山市)
    • Year and Date
      2014-07-30 – 2014-08-01
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] Pifithrin-&#61549;, an inhibitor of HSP70, can increase the antitumor effects of hyperthermia against human prostate cancer cells

    • Author(s)
      Mamoru Harada
    • Organizer
      、The 6th ACHO & the 31st JCTM
    • Place of Presentation
      福井県民ホールAOSSA(福井市)
    • Year and Date
      2014-09-04 – 2014-09-06
    • Invited
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] シイタケ菌糸体抽出物とgemcitabineの併用はTregとMDSCを抑制することで相乗的な抗腫瘍効果を発揮す

    • Author(s)
      石川悟、和知俊、松井保公、山口博史、原田
    • Organizer
      第73回日本癌学会総会
    • Place of Presentation
      パシフィコ横浜(横浜市
    • Year and Date
      2014-09-25 – 2014-09-27
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] 可溶性ST2は炎症性のがん微小環境を修飾し膵臓がんの腫瘍血管新生と増殖を抑制する

    • Author(s)
      秋元美穂、原田守、竹永啓三
    • Organizer
      第73回日本癌学会総会
    • Place of Presentation
      パシフィコ横浜(横浜市
    • Year and Date
      2014-09-25 – 2014-09-27
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] Combination of low-dose and intermittent chemotherapy with cyclophosphamide and gemcitabine restores efficacy of anti-CD137 antibody therapy at the late tumor-bearing state

    • Author(s)
      Harada M, Tamada K, Harashima N
    • Organizer
      第43回日本免疫学会総会
    • Place of Presentation
      国立京都国際会館(京都市)
    • Year and Date
      2014-12-10 – 2014-12-12
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] ABT-263はヒト膵がん細胞のTRAILによるアポトーシスを増強する

    • Author(s)
      波里瑶子、原嶋奈々江、門馬浩行、田島義証、原田守
    • Organizer
      第73回日本癌学会総会
    • Place of Presentation
      パシフィコ横浜(横浜市
    • Year and Date
      2014-09-25 – 2014-09-27
    • Data Source
      KAKENHI-PROJECT-24501331
  • [Presentation] ヒト膵癌細胞に対するTRAILとchloroquine の併用効果の検討

    • Author(s)
      門馬浩行、原嶋奈々江、波里瑶子、田島 義証、原田守
    • Organizer
      第18回日本がん免疫学会
    • Place of Presentation
      ひめぎんホール(松山市)
    • Year and Date
      2014-07-30 – 2014-08-01
    • Data Source
      KAKENHI-PROJECT-24501331
  • []

  • 1.  DE VELASCO Marco (20449838)
    # of Collaborated Projects: 5 results
    # of Collaborated Products: 3 results
  • 2.  UEMURA Hirotsugu (90213397)
    # of Collaborated Projects: 5 results
    # of Collaborated Products: 3 results
  • 3.  MINAMI Takafumi (70340809)
    # of Collaborated Projects: 5 results
    # of Collaborated Products: 3 results
  • 4.  YOSHIMURA Kazuhiro (20283757)
    # of Collaborated Projects: 3 results
    # of Collaborated Products: 3 results
  • 5.  吉田 裕樹 (40260715)
    # of Collaborated Projects: 2 results
    # of Collaborated Products: 0 results
  • 6.  MUTA Hiromi (40325478)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 7.  TANI Kenzaburo (00183864)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 8.  岸原 健二 (80214774)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 9.  松崎 吾朗 (30229455)
    # of Collaborated Projects: 1 results
    # of Collaborated Products: 0 results
  • 10.  KOTANI Hitoshi
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 4 results
  • 11.  KOMOHARA Yoshihiro
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 12.  FUJIWARA Yukio
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 13.  OKANO Shinji
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 14.  今村 龍
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 15.  川内 秀之
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 16.  矢野 浩夢
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 17.  谷浦 隆仁
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 18.  相島 慎一
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 19.  吉住 朋晴
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 20.  副島 雄二
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 21.  池上 徹
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 22.  前原 喜彦
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 23.  調 憲
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 1 results
  • 24.  原嶋 奈々江
    # of Collaborated Projects: 0 results
    # of Collaborated Products: 3 results

URL: 

Are you sure that you want to link your ORCID iD to your KAKEN Researcher profile?
* This action can be performed only by the researcher himself/herself who is listed on the KAKEN Researcher’s page. Are you sure that this KAKEN Researcher’s page is your page?

この研究者とORCID iDの連携を行いますか?
※ この処理は、研究者本人だけが実行できます。

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi